Researchers are investigating the safety and effectiveness of a new gene therapy product that replaces the defective β-sarcoglycan gene.
Clinical use of large-scale genetic screening helped end the diagnostic odyssey for many patients with nonspecific neuromuscular phenotypes.
Genome-wide association study identifies two variants that may yield therapies for children with DMD.
A meta-analysis shows people who have experienced concussion and/or mild traumatic brain injury are more likely to attempt suicide and to have suicidal ideation than people who have not experienced the injuries.
Study also indicates early treatment may provide best outcomes.
You Might Also Be Interested In
Sign Up for PediatricsOnline
Subscribe to PediatricsOnline, a bi-monthly electronic newsletter featuring medical stories, clinical case studies, research announcements and other news from Nationwide Children's Hospital.
We offer comprehensive, family-centered care from renowned experts in pediatric neurology. We participate in clinical and scientific research programs, and our faculty members play prominent roles in national and international neurological organizations.